Celcuity CELC
NASDAQ CELC
$95.70 -0.73 (-0.76%)
As of: Sep 4, 2026 · 3:59 PM EDT

Celcuity (CELC) Cash & Equivalents (2016 - 2026)

Celcuity's (CELC) quarterly Cash & Equivalents came in at $441.5 million in Q4 2025, up 1862.22% YoY from $22.5 million in Q4 2024, and up 494.6% on a QoQ basis from $74.3 million in Q3 2025.

Analysis

Celcuity (CELC) Cash & Equivalents (2016 - 2026) Analysis & Trends

Celcuity (CELC) has 10 years of Cash & Equivalents data on file, last reported at $441.5 million in Q4 2025.

  • Quarterly Cash & Equivalents rose 1862.22% year-over-year to $441.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $441.5 million (up 1862.22% YoY) and the FY2025 annual result came in at $441.5 million, up 1862.22% from the prior year.
  • Cash & Equivalents advanced to $441.5 million in Q4 2025, from $74.3 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $441.5 million in Q4 2025 to a low of $12.6 million in Q3 2024.
  • A 5-year average of $63.8 million and a median of $34.3 million in 2021 frame the typical range for Cash & Equivalents.
  • Annual changes were most pronounced in 2022 — Cash & Equivalents tumbled 70.85% — and 2025, when it jumped 1862.22%.
  • Tracing CELC's Cash & Equivalents over 5 years: stood at $84.3 million in 2021, then sank by 70.85% to $24.6 million in 2022, then grew by 24.79% to $30.7 million in 2023, then declined by 26.62% to $22.5 million in 2024, then jumped by 1862.22% to $441.5 million in 2025.
  • The last three Cash & Equivalents figures came in at $441.5 million (Q4 2025), $74.3 million (Q3 2025), and $46.4 million (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 6.14 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 2.46 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 3.58 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 1.72 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 815.44 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 5.10 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 1.71 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 811.99 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 544.80 Mn
10 Celcuity 5.25 Bn 5.25 Bn - 754.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 754.00 Mn
Dec 31, 2025 165.70 Mn
Sep 30, 2025 74.25 Mn
Jun 30, 2025 46.35 Mn
Mar 31, 2025 16.48 Mn
Dec 31, 2024 22.52 Mn
Sep 30, 2024 12.60 Mn
Jun 30, 2024 30.46 Mn
Mar 31, 2024 31.21 Mn
Dec 31, 2023 30.66 Mn
Sep 30, 2023 25.76 Mn
Jun 30, 2023 32.24 Mn
Mar 31, 2023 33.64 Mn
Dec 31, 2022 24.57 Mn
Sep 30, 2022 57.48 Mn
Jun 30, 2022 66.91 Mn
Mar 31, 2022 78.30 Mn
Dec 31, 2021 84.29 Mn
Sep 30, 2021 90.37 Mn
Jun 30, 2021 41.64 Mn